[go: up one dir, main page]

NO20010946D0 - Karbamat og ureasammensetninger og nevrotrofiske anvendelser - Google Patents

Karbamat og ureasammensetninger og nevrotrofiske anvendelser

Info

Publication number
NO20010946D0
NO20010946D0 NO20010946A NO20010946A NO20010946D0 NO 20010946 D0 NO20010946 D0 NO 20010946D0 NO 20010946 A NO20010946 A NO 20010946A NO 20010946 A NO20010946 A NO 20010946A NO 20010946 D0 NO20010946 D0 NO 20010946D0
Authority
NO
Norway
Prior art keywords
neurotrophic
carbamate
applications
urea compositions
urea
Prior art date
Application number
NO20010946A
Other languages
English (en)
Other versions
NO20010946L (no
Inventor
Jia-He Li
Joseph P Steiner
Gregory S Hamilton
Original Assignee
Guilford Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guilford Pharm Inc filed Critical Guilford Pharm Inc
Publication of NO20010946L publication Critical patent/NO20010946L/no
Publication of NO20010946D0 publication Critical patent/NO20010946D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20010946A 1998-08-25 2001-02-23 Karbamat og ureasammensetninger og nevrotrofiske anvendelser NO20010946D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/139,672 US6242468B1 (en) 1997-02-27 1998-08-25 Carbamate and urea compositions and neurotrophic uses
PCT/US1999/019261 WO2000010553A2 (en) 1998-08-25 1999-08-24 Carbamate and urea compositions and neurotrophic uses

Publications (2)

Publication Number Publication Date
NO20010946L NO20010946L (no) 2001-02-23
NO20010946D0 true NO20010946D0 (no) 2001-02-23

Family

ID=22487769

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010946A NO20010946D0 (no) 1998-08-25 2001-02-23 Karbamat og ureasammensetninger og nevrotrofiske anvendelser

Country Status (18)

Country Link
US (1) US6242468B1 (no)
EP (1) EP1107757A2 (no)
JP (1) JP2002523367A (no)
KR (1) KR20010072992A (no)
CN (1) CN1313767A (no)
AU (1) AU5687999A (no)
BG (1) BG105340A (no)
BR (1) BR9912988A (no)
CA (1) CA2341530A1 (no)
CZ (1) CZ2001274A3 (no)
EA (1) EA200100271A1 (no)
HU (1) HUP0103166A3 (no)
IL (1) IL140958A0 (no)
MX (1) MXPA01001937A (no)
NO (1) NO20010946D0 (no)
PL (1) PL346759A1 (no)
SK (1) SK2562001A3 (no)
WO (1) WO2000010553A2 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7008960B1 (en) 1999-03-02 2006-03-07 Vitreo-Retinal Technologies, Inc. Agents for intravitreal administration to treat or prevent disorders of the eye
AU6075400A (en) * 1999-07-06 2001-01-22 Vertex Pharmaceuticals Incorporated N-substituted glycine derivatives
US7977385B2 (en) * 2000-03-02 2011-07-12 Numoda Biotechnologies, Inc. Agents for corneal or intrastromal administration to treat or prevent disorders of the eye
US20030199574A1 (en) * 2000-03-02 2003-10-23 Vitreo-Retinal Technologies, Inc. Treatment of ophthalmic disorders using urea and urea derivatives
US20050137124A1 (en) * 2002-08-09 2005-06-23 Vitreo-Retinal Technologies, Inc. A California Corporation Agents for intravitreal administration to treat or prevent disorders of the eye
EP1402888A1 (en) * 2002-09-18 2004-03-31 Jerini AG The use of substituted carbocyclic compounds as rotamases inhibitors
BRPI0508084A (pt) * 2004-03-02 2007-07-17 Wyeth Corp método para o tratamento de um distúrbio neurológico, e, uso de meridamicina ou um sal do mesmo
GT200500035A (es) 2004-03-02 2005-10-24 Macrolidos y metodos para producir los mismos
WO2007061554A2 (en) * 2005-10-21 2007-05-31 Purdue Research Foundation Dosage of 4-aminopyridine derivatives for treatment of central nervous system injuries
ES2716832T3 (es) * 2011-12-27 2019-06-17 Bio Pharm Solutions Co Ltd Compuestos carbamatos de fenilo para su uso en el alivio o el tratamiento del dolor y el dolor neuropático

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI874163L (fi) 1986-09-26 1988-03-27 Mitsui Toatsu Chemicals Katekolderivat samt preparat innehaollande desamma foer haemmande och botande av regressiva sjukdomar i det centrala nervsystemet.
US5214034A (en) 1986-09-26 1993-05-25 Mitsui Toatsu Chemicals, Incorporated Catechol derivatives, and preventive and remedial preparations for regressive disorders in the central nervous system containing the same
IT1206078B (it) 1987-06-03 1989-04-14 Polifarma Spa Procedimento per la produzione di acido 3-indolpiruvico e suoi derivati loro uso farmaceutico
US5232923A (en) 1988-03-18 1993-08-03 Mitsui Toatsu Chemicals, Incorporated Catechol derivatives and pharmaceutical preparations containing same
US5166317A (en) 1988-10-31 1992-11-24 Houston Biotechnology Incorporated Neurotrophic factor
US5215969A (en) 1989-08-11 1993-06-01 Hahnemann University Dopaminergic neurotrophic factor for treatment of Parkinson's disease
US5620971A (en) 1991-05-09 1997-04-15 Vertex Pharmaceuticals Incorporated Biologically active acylated amino acid derivatives
US5744485A (en) 1994-03-25 1998-04-28 Vertex Pharmaceuticals Incorporated Carbamates and ureas as modifiers of multi-drug resistance
IL115685A (en) * 1994-11-16 2000-08-31 Vertex Pharma Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
US6037370A (en) 1995-06-08 2000-03-14 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5717092A (en) 1996-03-29 1998-02-10 Vertex Pharmaceuticals Inc. Compounds with improved multi-drug resistance activity
US5811434A (en) 1996-11-13 1998-09-22 Vertex Pharmacueticals Incorporated Methods and compositions for stimulating neurite growth
US5840736A (en) 1996-11-13 1998-11-24 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5780484A (en) 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds
US5935989A (en) * 1996-12-31 1999-08-10 Gpi Nil Holdings Inc. N-linked ureas and carbamates of heterocyclic thioesters
ZA98825B (en) * 1997-02-27 1998-10-19 Guilford Pharm Inc Method of using neurotrophic carbamates and ureas

Also Published As

Publication number Publication date
BG105340A (en) 2001-12-29
US6242468B1 (en) 2001-06-05
KR20010072992A (ko) 2001-07-31
HUP0103166A2 (hu) 2002-05-29
HUP0103166A3 (en) 2002-10-28
WO2000010553A3 (en) 2000-05-18
MXPA01001937A (es) 2002-04-24
BR9912988A (pt) 2001-10-02
NO20010946L (no) 2001-02-23
JP2002523367A (ja) 2002-07-30
IL140958A0 (en) 2002-02-10
PL346759A1 (en) 2002-02-25
EP1107757A2 (en) 2001-06-20
EA200100271A1 (ru) 2001-10-22
WO2000010553A2 (en) 2000-03-02
CA2341530A1 (en) 2000-03-02
SK2562001A3 (en) 2001-09-11
CN1313767A (zh) 2001-09-19
AU5687999A (en) 2000-03-14
CZ2001274A3 (cs) 2001-09-12

Similar Documents

Publication Publication Date Title
NO20032753D0 (no) Forbindelse og anvendelse derav
NO20006488D0 (no) Sammensetning og anvendelse
DK1084104T3 (da) Nitrogenoxidsynthaseinhibitorer
DK1194037T3 (da) Agrokemiske sammensætninger og overfladeaktive forbindelser
NO20000011D0 (no) Skumdempersammensetninger og fremgangsmåter
ATE232556T1 (de) Brausezusammensetzungen sowie trockene brausegranulate
EP1298180A4 (en) HYDROPHOBIC AND LIPOPHOBE COMPOSITION
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
DK1089726T3 (da) Præparat omfattende beta-hydroxy-beta-methylsmørsyre og mindst en aminosyre
DK0969836T3 (da) Lactosefri, ikke-vandsugende og vandfri farmaceutiske sammensætninger af descarbethoxyloratadin
DE69830372D1 (de) Gaserzeugende zusammensetzung und formmasse davon
PT1139761E (pt) Composicoes herbicidas e concentrados tensioactivos
DK1112003T3 (da) Ny sammensætning og anvendelse
DK0970137T3 (da) Overtrækkende, klæbende og forseglende sammensætninger
DE59911978D1 (de) Carbamatlösungen
DE69807911D1 (de) Vernetzbare zusammensetzung
DE69910714D1 (de) Pflanzenaktivierungsmittel
DE60230245D1 (de) Wabenkonstruktion und deren zusammenbau
DE69928233D1 (de) Durchflussaufnehmer und wandler
IS2841B (is) Samstæða hluta og lyfjasamsetningar
NO20013237L (no) 3,3-biarylpiperidin og 2,2-biarylmorfolinderivater
NO985891D0 (no) Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler
DE69916694D1 (de) 2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on
NO20010946D0 (no) Karbamat og ureasammensetninger og nevrotrofiske anvendelser
PT1017281E (pt) Metodos e composicoes herbicidas sinergicas

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application